154 related articles for article (PubMed ID: 23197684)
1. Gender differences in clinical presentation and prognosis of uveal melanoma.
Zloto O; Pe'er J; Frenkel S
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):652-6. PubMed ID: 23197684
[TBL] [Abstract][Full Text] [Related]
2. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
Frenkel S; Hendler K; Pe'er J
Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
[TBL] [Abstract][Full Text] [Related]
3. Uveal metastasis revealing lung cancer.
Meziani L; Cassoux N; Le Rouic LL; Gabriel CL; Dendale R; Sastre X; Catherine D; Livartowski A; Plancher C; Asselain B; Desjardins L
J Fr Ophtalmol; 2012 Jun; 35(6):420-5. PubMed ID: 22633214
[TBL] [Abstract][Full Text] [Related]
4. Relative survival of patients with uveal melanoma managed in a single center.
Caminal JM; Ribes J; Clèries R; Ibáñez N; Arias L; Piulats JM; Pera J; Gutierrez C; Arruga J
Melanoma Res; 2012 Jun; 22(3):271-7. PubMed ID: 22516965
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
[TBL] [Abstract][Full Text] [Related]
6. Uveal melanoma in England: trends over time and geographical variation.
Keenan TD; Yeates D; Goldacre MJ
Br J Ophthalmol; 2012 Nov; 96(11):1415-9. PubMed ID: 22976582
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in the outcome of cardiac interventions.
Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
[TBL] [Abstract][Full Text] [Related]
8. Incidence of uveal melanoma in Sweden from 1960 to 1998.
Bergman L; Seregard S; Nilsson B; Ringborg U; Lundell G; Ragnarsson-Olding B
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2579-83. PubMed ID: 12147588
[TBL] [Abstract][Full Text] [Related]
9. ["Melanoma 92". epidemiological study of uveal melanoma in France].
Vidal JL; Bacin F; Albuisson E; Rozan R; Desjardins L; D'Hermies F; Grange JD; Chauvel P; Caujolle JP; Sahel J
J Fr Ophtalmol; 1995; 18(8-9):520-8. PubMed ID: 7560797
[TBL] [Abstract][Full Text] [Related]
10. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal disease.
Cerbone L; Van Ginderdeuren R; Van den Oord J; Fieuws S; Spileers W; Van Eenoo L; Wozniak A; Sternberg CN; Schöffski P
Oncology; 2014; 86(3):185-9. PubMed ID: 24776955
[TBL] [Abstract][Full Text] [Related]
12. Uveal melanoma among Finnish children and young adults.
Al-Jamal RT; Kivelä T
J AAPOS; 2014 Feb; 18(1):61-6. PubMed ID: 24568985
[TBL] [Abstract][Full Text] [Related]
13. Mortality after uveal and conjunctival melanoma: which tumour is more deadly?
Kujala E; Tuomaala S; Eskelin S; Kivelä T
Acta Ophthalmol; 2009 Mar; 87(2):149-53. PubMed ID: 18937804
[TBL] [Abstract][Full Text] [Related]
14. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
15. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
[TBL] [Abstract][Full Text] [Related]
16. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.
Valsecchi ME; Orloff M; Sato R; Chervoneva I; Shields CL; Shields JA; Mastrangelo MJ; Sato T
Ophthalmology; 2018 Feb; 125(2):210-217. PubMed ID: 28935400
[TBL] [Abstract][Full Text] [Related]
18. Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis.
Delgado-Ramos GM; Thomas F; VanderWalde A; King B; Wilson M; Pallera AM
Med Oncol; 2019 Jan; 36(2):17. PubMed ID: 30666496
[TBL] [Abstract][Full Text] [Related]
19. Conjunctival melanoma in the Netherlands: a nationwide study.
Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
[TBL] [Abstract][Full Text] [Related]
20. Occupational risks for uveal melanoma results from a case-control study in nine European countries.
Lutz JM; Cree I; Sabroe S; Kvist TK; Clausen LB; Afonso N; Ahrens W; Ballard TJ; Bell J; Cyr D; Eriksson M; Févotte J; Guénel P; Hardell L; Jöckel KH; Miranda A; Merletti F; Morales-Suarez-Varela MM; Stengrevics A; Lynge E
Cancer Causes Control; 2005 May; 16(4):437-47. PubMed ID: 15953986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
